Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

Rothman Institute Orthopaedics1 site in 1 countryAugust 4, 2009

ConditionsOsteoarthritis of the Hip

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Osteoarthritis of the Hip
Sponsor: Rothman Institute Orthopaedics
Locations: 1
Primary Endpoint: The outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stem
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.

Registry

clinicaltrials.gov

Start Date

August 4, 2009

End Date

TBD

Last Updated

13 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Rothman Institute Orthopaedics

Eligibility Criteria

Inclusion Criteria

•All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem.
•Patients with hip fracture undergoing THA will also be included.
•Patients willing and able to comply with follow-up requirements and self-evaluations.

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

The outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stem